However, further biomarker studies are still needed to confirm the prognostic role of fibulin-3 in bladder cancer, and the mechanisms underlying fibulin-3 role in aggressive bladder cancer behavior are still poorly understood. This evidence concerns the gene EFEMP1 and urinary bladder cancer.